Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity.
about
PEGylated Adenoviruses: From Mice to MonkeysPharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study.Cell-based and animal models for hepatitis B and C viruses.Biodegradable nanogels for oral delivery of interferon for norovirus infectionDevelopment of a novel DDS for site-specific PEGylated proteins.Preparation, characterization, in vitro release and degradation of cathelicidin-BF-30-PLGA microspheres.Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeuticsTreatment of interferon-alpha for chronic hepatitis C.Bio-inspired liposomal thrombomodulin conjugate through bio-orthogonal chemistry.Development of novel drug delivery systems using phage display technology for clinical application of protein drugsSite of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway.Molecular biology of liver disorders:the hepatitis C virus and molecular targets for drug development.Optimization of random PEGylation reactions by means of high throughput screening."Bio"-macromolecules: polymer-protein conjugates as emerging scaffolds for therapeutics.PEGylation of a High-Affinity Anti-(+)Methamphetamine Single Chain Antibody Fragment Extends Functional Half-Life by Reducing Clearance.
P2860
Q24635276-EB004609-E51B-4231-9932-5A44950A45BCQ33336647-96648ADE-C092-409E-A988-E5DE2BFF4ED7Q33392904-2DF853AF-9CD8-4C55-9B66-F6C1B7EF111CQ33702348-0B572A98-DF55-4CC8-BE92-721F04145FBEQ34525191-B3CD67F5-C178-4002-A613-1A46BC8F13B3Q35040200-9E47998F-7142-4427-8591-F8FE77640C7EQ35194563-4EF5EAEE-CE46-468D-ACDB-056054FA88B8Q35223810-877FE942-0CDF-4DE0-ABC5-E966CD7E42E9Q36491803-828B5001-B77D-435C-BA6F-6BAF43BE9884Q36778167-21D1E060-B00F-44F5-80AD-05C4FCF175C5Q37198453-22E75D78-105B-4DA9-83C1-613812DE75A8Q40481236-E86CAB4E-F00D-4192-B2AF-7E76B7677023Q42264259-C979975E-2369-4C93-AC9C-ED1527F010CAQ45178029-90EE9C97-7258-42D7-8DA7-78B1B36B3D4DQ46335892-F3B8C3E7-C910-4BDE-8135-2B3160ED5A2DQ53891489-51DD91B9-A0E8-4AE2-BE2E-5CA611185F36
P2860
Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Positional isomers of monopegy ...... tion, and biological activity.
@en
type
label
Positional isomers of monopegy ...... tion, and biological activity.
@en
prefLabel
Positional isomers of monopegy ...... tion, and biological activity.
@en
P2093
P356
P1476
Positional isomers of monopegy ...... tion, and biological activity.
@en
P2093
A Palleroni
B DeBarbieri
E Russoman
J E Porter
K Hollfelder
M C Graves
P304
P356
10.1006/ABIO.1997.2128
P407
P577
1997-05-01T00:00:00Z